Abstract
Visceral leishmaniasis can rarely be unmasked by immune reconstitution in human immunodeficiency virus (HIV)-1-infected patients. We report the first case of immune reconstitution associated with leishmaniasis in an HIV patient to be imaged with [18F]fluorodeoxyglucose positron emission tomography (FDG/PET), at both baseline and after therapy.
This is a preview of subscription content, log in via an institution to check access.
References
Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M; IeDEA Southern and Central Africa. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:251–61.
Berry A, Abraham B, Dereure J, Pinzani V, Bastien P, Reynes J. Two case reports of symptomatic visceral leishmaniasis in AIDS patients concomitant with immune reconstitution due to antiretroviral therapy. Scand J Infect Dis. 2004;36:225–7.
Lawn SD, Wilkinson RJ. Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. Parasite Immunol. 2006;28:625–33.
Castaigne C, Tondeur M, de Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun. 2009;30:41–7.
O’Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997;38:1575–83.
Mortensen BK, Nielsen SD, Christensen CB, Helweg-Larsen J. Immune reconstitution syndrome presenting as probable AIDS-related lymphoma: a case report. AIDS Res Ther. 2011;8:34.
Casabianca A, Marchetti M, Zallio F, Feyles E, Concialdi E, Ferroglio E, Biglino A. Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment. Infection. 2011;39:375–8.
Donati P, Paolino G, Panetta C, Muscardin L, Cota C, Giuliani M. Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient. Infection. 2013;41:575–8
del Giudice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty P, Gastaut JA, Costagliola D, Rosenthal E; French Hospital Database on HIV Clinical Epidemiologic Group. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis. 2002;186:1366–70.
Albrecht H. Leishmaniosis—new perspectives on an underappreciated opportunistic infection. AIDS. 1998;12:2225–6.
de la Rosa R, Pineda JA, Delgado J, Macías J, Morillas F, Martín-Sánchez J Leal M, Sánchez-Quijano A, Lissen E. Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect Dis. 2001;32:633–5.
Lupi A, Todeschini G, Zanco P. Diffuse metabolic activation of reticuloendothelium on F-18 FDG PET imaging in a case of visceral leishmania. Clin Nucl Med. 2006;31:34–6.
Yapar AF, Reyhan M, Kocer NE, Aydin M, Nursal GN. Diffuse splenic F-18 FDG uptake in visceral leishmaniasis. Clin Nucl Med. 2011;36:1041–3.
Sathekge M, Maes A, Kgomo M, Stoltz A, Van de Wiele C. Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis. J Nucl Med. 2011;52:880–5.
Acknowledgments
The authors do not have any funding acknowledgements.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kyrtatos, P.G., Debard, A., Martin-Blondel, G. et al. FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasis. Infection 41, 1017–1019 (2013). https://doi.org/10.1007/s15010-013-0459-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-013-0459-2